Manufacturer of pharmaceuticals
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act. Monitored issues related to NAFTA. Issues related to antimicrobials; issues related to the reauthorization of PAHPA, including S. 2852 / H.R. 6378, Pandemic All Hazards Preparedness Act of 2018. Monitored issues related to drug pricing; S. 3787, The Developing and Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2018.
BUD - Budget/Appropriations TRD - Trade (domestic/foreign) HCR - Health Issues MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER RACHEL JONES HENSLER STACEY HUGHES STACEY HUGHES EMILY PORTER STEPHANIE BADGER STACEY HUGHES EMILY PORTER